Related Articles
Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma
Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time
Selective prognostic impact of serum α-fetoprotein level in patients with hepatocellular carcinoma: Analysis of 543 patients in a single center